Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai New Asiatic Pharmaceutical
Shanghai, Shanghai, China
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
The company has several marketed and late-stage assets (notably loperamide hydrochloride for diarrhea, timolol maleate for hemangioma, and benvitimod for moderate atopic dermatitis). The pipeline comprises approved products and phase 3/NDA-stage candidates addressing neoplasms, immune disorders, and other diseases. It is part of Shanghai Pharmaceuticals, a top-three pharma in China, supporting broad coverage across chemical drugs, biologics, and modern TCM, with a focus on high-value generics, innovative drugs, and rare diseases[1][5][2].
- Therapeutic areas
- ImmunologyGastroenterologyHematologyDermatologyOncologyWomen's Health
- Modalities
- Small moleculeMonoclonal antibodyBiologicTraditional Chinese medicine
- Industry
- Biotech
02
Partnerships
ImmViraLumosa Therapeutics
Beyond the preview
Go deeper on Shanghai New Asiatic Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai New Asiatic Pharmaceutical.